Overcoming the challenge of patient compliance with iron chelation therapy.
Cappellini
M D
MD
Centro Anemie Cogenite, Ospedale maggiore Policlinico, IRCCS, University of Milan, Milano, Italy. maria.cappellini@unimi.it
D003676:Deferoxamine / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D006801:Humans; D007263:Infusions, Parenteral / Q000009:adverse effects; D007502:Iron Chelating Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D019190:Iron Overload / Q000188:drug therapy* / Q000401:mortality; D010349:Patient Compliance / Q000523:psychology*; D010353:Patient Education as Topic; D010817:Physician-Patient Relations; D015996:Survival Rate
D007502:Iron Chelating Agents; D003676:Deferoxamine